GRIA2 and metabolic syndrome: Therefore, the Gria2/cAMP axis may exert pleiotropic effects by coordinating multiple aging‐related pathways, ultimately contributing to the observed improvements in dyslipidemia, reduction of senescence‐associated secretory phenotype (SASP) factors and oxidative stress, downregulation of cellular senescence markers and alleviation of DNA damage in the carotid artery tissues of rats treated with XML or injected with Gria2‐overexpressing EPCs.